天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]-

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]- Struktur
1691240-78-4
CAS-Nr.
1691240-78-4
Englisch Name:
2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]-
Synonyma:
Nafithromycin;2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]-
CBNumber:
CB58107179
Summenformel:
C42H62N6O11S
Molgewicht:
859.05
MOL-Datei:
1691240-78-4.mol

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]- Eigenschaften

Siedepunkt:
939.5±75.0 °C(Predicted)
Dichte
1.36±0.1 g/cm3(Predicted)
pka
10.81±0.70(Predicted)

Sicherheit

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]- Chemische Eigenschaften,Einsatz,Produktion Methoden

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chengdu Peter-like Biotechnology Co., Ltd. 028-81700200 13308200041
 2851167782@qq.com China 11183 58
  • 2H-Furo[2,3-c]oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-[(1S)-1-[5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl]ethoxy]-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [C(Z),3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS]-
  • Nafithromycin
  • 1691240-78-4
  • C42H62N6O11S
Copyright 2019 ? ChemicalBook. All rights reserved